Professor Luc Douay – President and Scientific Director
The company’s scientific and medical expert, and project leader.
Hematology professor at Sorbonne University, former head of the Biological Hematology Department at Saint Antoine Hospital in Paris, former joint Inserm/Sorbonne University research team supervisor, former Medical and Scientific Director at Agence Française du Sang [AFS - French Blood Agency], former Scientific Director of Cell Therapy at EFS [Etablissement français du sang - French Blood Institute] in the Ile-de-France region. Internationally renowned opinion leader in the field. MD, PhD
Daniel Marini - Chief Executive Officer
Former senior executive at Elf Atochem and Arkema, as vice-president of international business units and ceo of subsidiaries, with a background in chemical and process engineering, and former Director of Economic and International Affairs at Union des industries Chimiques [Federation of Chemical Industries].
In charge of strategy, organization, human resources, and partnerships.
Civil engineer (Ecole Mines ParisTech)
Loïc Tron - Chief Operating Officer
In charge of finance, administration, legal matters, and purchasing.
His experience with startups has allowed him to manage every aspect in creating the company, and lead the initial fundraising campaign. Engineer (Ecole Polytechnique) and civil engineer (Ecole Mines ParisTech)
Guillaume Rousseau - R&D Director
His thesis, while part of Professor Douay's team, established the industrial basis for developing the technological and biological processes for producing cultured red blood cells from hematopoietic stem cells.
Engineer (Ecole Polytechnique) and civil engineer (Ecole Mines ParisTech), PhD in science